Global cancer burden grows as NHS England launches national gene testing programme
Ahead of World Cancer Day on 4 February, the World Health Organization (WHO) has released new figures showing that the global cancer burden is growing. The survey undertaken by the WHO’s cancer agency, the International Agency for Research on Cancer (IARC), shows a growing need for more cancer-related health services worldwide. Figures from 2022 show... Read moreThe post Global cancer burden grows as NHS England launches national gene testing programme appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 1, 2024 Category: Nursing Authors: Carolyn Scott Tags: Cancer BRCA gene testing Breast cancer colorectal cancer lung cancer prostate cancer stomach cancer Source Type: news
World Cancer Day 2024
Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household (1). Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people and communities (2).
In the WHO Eastern Mediterranean Region alone, more than 788 000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in...
Source: WHO EMRO News - February 1, 2024 Category: Middle East Health Source Type: news
I ignored these cancer symptoms for years because I was scared - now I could die within months at 31
A 31-year-old woman from Washington state revealed she was diagnosed with end-stage colon cancer after ignoring concerning symptoms for three years out of fear. (Source: the Mail online | Health)
Source: the Mail online | Health - January 31, 2024 Category: Consumer Health News Source Type: news
Liver Status Improves Targeted Therapy Selection in Mets CRC Liver Status Improves Targeted Therapy Selection in Mets CRC
Adding liver metastases status to tumor sidedness may enhance first-line targeted treatment selection in certain patients with metastatic colorectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Unfavorable Colon Cancer Trends in Young Adults Seen Across the Pond, Too
(MedPage Today) -- Colorectal cancer (CRC) mortality rates in the European Union (EU) and the U.K. have declined since 2018, a new study showed, but trends among younger adults are raising concern.
Using data from the WHO and Eurostat databases... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 30, 2024 Category: Gastroenterology Source Type: news
Next time your doctor orders a scan, know the benefits but don ’t forget to ask about the harm | Ranjana Srivastava
‘Incidentalomas’ – purely incidental findings – arise in up to a third of all tests. Patients can end up with unnecessary and harmful interventionsGet ourmorning and afternoon news emails,free app ordaily news podcast“And one more thing, what do you want to do about this?”The trainee looks so apologetic that I suspect a medical error relating to our octogenarian patient admitted overnight with confusion. Scrolling through the images on the computer, I see the problem, even without the arrows pointing to an “ill-defined abnormality” around the colon.Sign up for a weekly email featuring our best readsContinue...
Source: Guardian Unlimited Science - January 30, 2024 Category: Science Authors: Ranjana Srivastava Tags: Health Australia news Cancer Medical research Doctors Source Type: news
CRC Risk Increasing Across Successive Birth Cohorts CRC Risk Increasing Across Successive Birth Cohorts
Colorectal cancer incidence is increasing in people aged 50-54 and younger than 50, and a prior decrease in incidence is flattening in individuals aged 55-74.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 30, 2024 Category: Internal Medicine Tags: Gastroenterology Source Type: news
Targeted Colorectal Cancer Combo Improves QoL Targeted Colorectal Cancer Combo Improves QoL
Patients with metastatic colorectal cancer who have the KRAS G12C mutation demonstrated improved quality of life following sotorasib and panitumumab compared with standard therapy.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 30, 2024 Category: Gastroenterology Tags: Hematology-Oncology Source Type: news
ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
MONDAY, Jan. 29, 2024 -- For patients with radically resected, stage II to IV colorectal cancer (CRC), circulating tumor (ct)DNA-based detection of molecular residual disease (MRD) in response to adjuvant chemotherapy (ACT) is prognostic of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2024 Category: Pharmaceuticals Source Type: news
Colorectal surgeon shares five signs of cancer to spot when you go to the toilet
From changes in your poo to how you feel during a number two, an expert has outlined five symptoms of bowel cancer that shouldn't be ignored. (Source: Daily Express - Health)
Source: Daily Express - Health - January 27, 2024 Category: Consumer Health News Source Type: news
CellMax Life Shares Positive Results From Validation Study for FirstSight ™ Blood Test for Detection of Colorectal Cancer and Pre-cancerous Advanced Adenomas
CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, presented the latest results from its independent external validation study on January 20, 2024 at the ASCO Gastrointestinal Cancers Symposium. Data from this... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 26, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Liquid Biopsy Has Mixed Performance for Predicting Colon Cancer Outcomes
(MedPage Today) -- SAN FRANCISCO -- In separate studies, liquid biopsy produced mixed results for guiding colon cancer treatment.
Adjuvant chemotherapy guided by postoperative circulating tumor (ct) DNA did not lead to higher rates of DNA clearance... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 24, 2024 Category: Gastroenterology Source Type: news
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
MADRID, Jan. 23, 2024 -- (Healthcare Sales & Marketing Network) -- Amadix, a Spanish biotech company, announced today that PreveCol®, its colorectal cancer screening blood test, has received Breakthrough Device Designation from the U.S. Food and Drug ... Diagnostics, Oncology, FDA Amadix , PreveCol , colorectal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2024 Category: Pharmaceuticals Source Type: news
Secrets of the microbiome: the gut – podcast
The trillions of microbes living on and inside the human body are an important part of who we are, from mediating all of our interactions with the environment to determining our cancer risk and influencing who we fall for. And scientists are only just beginning to decipher the species of bugs we share our lives with, and how they shape us.In the first of a Science Weekly three-part mini-series, Ian Sample speaks to colorectal surgeon and researcher, James Kinross, about the miraculous world of our gut microbiome, how modern life is impacting it, and what we can do to look after itContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 23, 2024 Category: Science Authors: Presented by Ian Sample, produced by Madeleine Finlay, sound design by Joel Cox, the executive producer is Ellie Bury Tags: Science Microbiology Cancer research Health Medical research Allergies Infectious diseases Mental health Source Type: news
Big PFS Improvement in Highly Mutated CRC With Dual Immunotherapy
(MedPage Today) -- SAN FRANCISCO -- Frontline dual immunotherapy significantly improved progression-free survival (PFS) versus chemotherapy in microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) metastatic colorectal cancer... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 22, 2024 Category: Gastroenterology Source Type: news
